The Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine and Skyland Trail will bring together leaders in the mental health field on Nov. 1 for Innovations in Mental Health, a symposium focusing on treatments, discoveries, and research in the field of behavioral health. Keynote speaker is former professor of psychiatry at Emory, Thomas R. Insel, MD, now director of the National Institutes of Mental Health (NIMH).
Government figures show that an estimated 22.1 million American adults suffer from some type of mental disorder. It is a leading source of disease burden in the United States, second only to cardiovascular conditions. Ignorance and stigma have caused a large percentage of the mentally ill to go untreated. However, recent efforts to educate the public about mental illness have spawned an awareness that has begun to peel away that stigma, generating a likelihood that the illness soon will be more readily recognized and treated.
Over the last decade, neuroscientists have made great strides in understanding the biological basis of mental illness. Advances in imaging technologies have led to a better understanding of the physiological workings of the brain and have been valuable in tracking the effects of medications. Studies are being done to determine what triggers mental illness and track the course of the disease so that preventive measures can be developed. New medications with less side effects are becoming available as well as innovative alternatives to medication for those who are resistant.
At this educational symposium, participants will hear from researchers and clinicians who not only have contributed to the progress that has been made, but who continue to work and to collaborate with other scientists to shape the future of psychiatry and mental healthcare.
Speakers include Floyd Bloom, MD, Chairman of the Department of Neuropharmacology, The Scripps Research Institute; Dwight Evans, MD, Professor and Chairman of the Department of Psychiatry, University of Pennsylvania School of Medicine; Martin Keller, MD, Professor and Chairman of the Department of Psychiatry, Brown University; Charles Nemeroff, MD, PhD, Professor and Chairman of the Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine; and Alan Schatzberg, MD, Professor and Chairman of the Department of Psychiatry, Stanford University School of Medicine.
The symposium will take place at Skyland Trail on Monday, Nov. 1, 2004, from 2-6 p.m. Presentations will be followed by a question and answer period. The symposium is free and open to the public; however seating is limited.
Register to attend at: www.skylandtrailevents.com, or for more information, call Lisa Tuttle at 404/315-8333.